What is Advanced Medical Solutions Group PS Ratio?
Advanced Medical Solutions GroupCHIX:AMSL +0.27%93 PS Ratio is 2.69 as of Jun. 30, 2026, which is 51% below its 10-year median of 5.54. GuruFocus rates CHIX:AMSL with a GF Score™ of 93/100 and a GF Value™ of £3.67 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 804 Medical Devices & Instruments companies, Advanced Medical Solutions Group ranks better than 53.11% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Advanced Medical Solutions Group's share price is £2.80.
Advanced Medical Solutions Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was £1.04. Hence, Advanced Medical Solutions Group's PS Ratio for today is 2.69.
Warning Sign:
Advanced Medical Solutions Group PLC stock PS Ratio (=2.69) is close to 1-year high of 2.78.
CHIX:AMSl'
s PS Ratio Range Over the Past 10 Years
Min: 1.84 Med: 5.54 Max: 8.93
Current: 2.71
During the past 13 years, Advanced Medical Solutions Group's highest PS Ratio was 8.93. The lowest was 1.84. And the median was 5.54.
CHIX:AMSl's PS Ratio is ranked better than 53.11% of 804
companies
in the Medical Devices & Instruments industry
Industry Median: 2.94
vs CHIX:AMSl: 2.71
During the past 13 years, Advanced Medical Solutions Group's highest 3-Year average Revenue per Share Growth Rate was 341.40% per year. The lowest was -14.00% per year. And the median was 12.50% per year.
Back to Basics: PS Ratio
Advanced Medical Solutions Group (CHIX:AMSl) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Advanced Medical Solutions Group PS Ratio Related Terms
Advanced Medical Solutions Group PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Advanced Medical Solutions Group's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Advanced Medical Solutions Group PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Advanced Medical Solutions Group's PS Ratio distribution charts can be found below:
* The bar in red indicates where Advanced Medical Solutions Group's PS Ratio falls into.
Advanced Medical Solutions Group PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Advanced Medical Solutions Group's Share Price of today is £2.80.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Advanced Medical Solutions Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was £1.04.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Advanced Medical Solutions Group (CHIX:AMSL) has a PS Ratio of 2.69 as of Jun. 30, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Advanced Medical Solutions Group and its competitors. This is 51% below median its historical median of 5.54. Over the past decade, Advanced Medical Solutions Group's PS Ratio has ranged from 1.84 to 8.93. According to the industry distribution chart, Advanced Medical Solutions Group ranks #377 out of 804 companies in the Medical Devices & Instruments industry, placing it in the top 46.9%.
Is Advanced Medical Solutions Group's PS Ratio too high?
Advanced Medical Solutions Group's current PS Ratio of 2.69 is 51% below median its 10-year median of 5.54. Over the past 10 years, this metric has ranged from a low of 1.84 to a high of 8.93. The Medical Devices & Instruments industry median PS Ratio is 2.94. Advanced Medical Solutions Group's value of 2.69 is 8.5% below this industry median. Based on the distribution chart, Advanced Medical Solutions Group ranks #377 out of 804 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Advanced Medical Solutions Group has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Advanced Medical Solutions Group's PS Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Advanced Medical Solutions Group ranks #377 out of 804 companies for PS Ratio. This puts Advanced Medical Solutions Group in the upper half of its industry. The industry median PS Ratio is 2.94. Advanced Medical Solutions Group's value of 2.69 is 8.5% below this benchmark. Historically, Advanced Medical Solutions Group's own PS Ratio has ranged from 1.84 to 8.93 over the past decade. While the company's 10-year median is 5.54 vs. the industry median of 2.94, Advanced Medical Solutions Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.94, based on 804 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Advanced Medical Solutions Group's current PS Ratio of 2.69 is 8.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Advanced Medical Solutions Group and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Advanced Medical Solutions Group's current PS Ratio is 2.69, which is 51% below median its own 10-year median of 5.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced Medical Solutions Group stock overvalued right now?
Based on GuruFocus' analysis, Advanced Medical Solutions Group (CHIX:AMSL) is currently considered Modestly Undervalued. The stock's GF Value™ is £3.67, compared to a current price of £2.80 — trading 23.7% below its estimated fair value. The current PS Ratio is 2.69, which is 51% below median its 10-year median of 5.54 and 8.5% below the Medical Devices & Instruments industry median of 2.94. Advanced Medical Solutions Group's overall GF Score™ is 93/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Advanced Medical Solutions Group (CHIX:AMSL), the current PS Ratio is 2.69 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Advanced Medical Solutions Group (CHIX:AMSL) Overvalued in 2026?
Based on GuruFocus' analysis, Advanced Medical Solutions Group stock appears to be undervalued.
The current stock price of £2.80 is trading 23.7% below its estimated GF Value™ of £3.67.
GuruFocus considers Advanced Medical Solutions Group to be Modestly Undervalued.
Key valuation signals for CHIX:AMSL:
PS Ratio: 2.69 (51% below median its 10-year median of 5.54)
GF Value™: £3.67 vs. price of £2.80 (23.7% below fair value)
Industry Position: 8.5% below the Medical Devices & Instruments median (#377 of 804)
No single metric tells the full story. See the CHIX:AMSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Advanced Medical Solutions Group Business Description
Advanced Medical Solutions Group PLC is engaged in developing and manufacturing wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The company's segment includes: Surgical and Woundcare, of which the Surgical segment derives maximum revenue. Geographically, the company operates in the United Kingdom, Germany, France, the rest of Europe, the United States of America, and the rest of the world.
93GF Score
Get the complete analysis for CHIX:AMSL
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:AMSL has been successfully added to your 
